SCHEMBL22680415

SCHEMBL22680415

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5c(c4)sc4cc6ccc7sc8ccccc8c7c6cc45)cc3)c3ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
MAPT P10636 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GPR3 P46089 1/20 0.35
F9 P00740 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
HSD17B1 P14061 1/20 0.34
CYP2B6 P20813 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B2 P37059 1/20 0.34
LIMK1 P53667 2/20 0.34
DUSP3 P51452 2/20 0.33
PIM3 Q86V86 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19109227 1.00 ESR1 (0.37) ESR1ESR2MAPTALDH1A1HPGD
SCHEMBL19109145 0.97 MAPT (0.37) ESR1ESR2MAPTALDH1A1HPGD
SCHEMBL24341039 0.96 MAPT (0.38) ESR1ESR2MAPTALDH1A1HPGD
SCHEMBL24341897 0.95 ESR1 (0.34) ESR1ESR2MAPTALDH1A1HPGD
SCHEMBL24341467 0.95 ESR1 (0.36) ESR1ESR2MAPTALDH1A1HPGD
SCHEMBL19109225 0.95 ESR1 (0.37) ESR1ESR2MAPTALDH1A1HPGD
SCHEMBL19109202 0.94 ESR1 (0.35) ESR1ESR2MAPTALDH1A1HPGD
SCHEMBL24341051 0.92 MAPT (0.35) ESR1ESR2MAPTALDH1A1HPGD
SCHEMBL19110322 0.92 MAPT (0.41) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19109312 0.92 MAPT (0.35) ESR1ESR2MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204521-A1 ELECTROACTIVE COMPOUNDS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2022-06-30 US disclosed
WO-2020231669-A1 ELECTROACTIVE COMPOUNDS DUPONT ELECTRONICS, INC. (US) 2020-11-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204521-A1 ELECTROACTIVE COMPOUNDS AHR, CYP1B1, KCNH1 ESR1 56/4885ESR2 38/4885MAPT 4722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.